EUROMEDICA Α.Ε.
Impressive financial results for Q3 2006 - Impressive increase of consolidated profits before taxes (117%) in comparison to the previous year''s results
The consolidated sales of Euromedica SA for Q3-2006, reached Euro 114.18 mil showing an increase of 16% in comparison to the previous year corresponding period. The profits before taxes reached Euro 9.74 mil from Euro 4.50 mil of the corresponding period of the previous year, showing an increase of 117%. The profits after taxes were doubled, and reached Euro 5.59 mil in Q3 2006 (from Euro 2.79 mil in Q3 2005).
At the same time the consolidated profits before taxes, financing, investment results and depreciation reached Euro 19.08 mil from Euro 13.36 mil (an increase of 43%). It is to be noted that the profits after taxes and minority rights reached Euro 3.96 mil from Euro 2.26 mil that were in Q3-2005 (an increase of 75%).
Equally impressive were the results of the parent company. Sales reached Euro 62.22 mil showing an increase of 13%. Results before taxes and minority rights reached Euro 2.65 mil in comparison to Euro 1.32 mil in Q3 2005, an increase of 101%.
''The impressive increase of the consolidated results of the Group'', as it was commented by the President of the Euromedica Group Mr Apostolos Terzopoulos, ''is the result of our long-run investment plan as well as of organisational interventions that led to a better control of operational costs''.
At the same time the consolidated profits before taxes, financing, investment results and depreciation reached Euro 19.08 mil from Euro 13.36 mil (an increase of 43%). It is to be noted that the profits after taxes and minority rights reached Euro 3.96 mil from Euro 2.26 mil that were in Q3-2005 (an increase of 75%).
Equally impressive were the results of the parent company. Sales reached Euro 62.22 mil showing an increase of 13%. Results before taxes and minority rights reached Euro 2.65 mil in comparison to Euro 1.32 mil in Q3 2005, an increase of 101%.
''The impressive increase of the consolidated results of the Group'', as it was commented by the President of the Euromedica Group Mr Apostolos Terzopoulos, ''is the result of our long-run investment plan as well as of organisational interventions that led to a better control of operational costs''.